Association between immune-related adverse events (irAEs) and atezolizumab efficacy in advanced NSCLC: analyses from the Ph III study OAK

Authors :: P Conkling
Julien Mazieres
Hina Patel
Fadi Braiteh
Marcus Ballinger
C.A. Thomas
Sylvia Hu
Niels Reinmuth
R Dziadziuszko
Kostas N. Syrigos
Diego Cortinovis
David R. Gandara
M. Gandhi
Louis Fehrenbacher
J. Goldschmidt
Rodolfo Bordoni
Michael P. Kosty
Source :: Pneumologie. 72:S56-S56
Publication Year :: 2018
Publisher :: Georg Thieme Verlag KG, 2018.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Immune system
business.industry
Atezolizumab
Internal medicine
Medicine
business
Adverse effect

Tools